barrest.gif (471 bytes)

The obtained results showed that 57,1% of the patients were cured and 33,3% improved and satisfied with the treatment, not needing a different therapeutic alternative. Using the reliability interval of 95%, at least 77% of the patients will be satisfied at the end of the therapeutic. Only 4,8% of the patients asked for another alternative in the treatment and the same percentage found themselves with an unaltered symptomatology. At the end of the passive phase, we verified that only 8,3% was cured.
The reduction of urine loss observed in the pad test was more emphatic in the passive phase than in the active one. This reduction depended on the initial value of the pad test. For each unit of variation of the initial pad test, the average reduction of the pad test grew in 0,36g.